GOSSAMER BIO, INC. (GOSS) Net income 2017–2025
GOSSAMER BIO, INC. (GOSS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$170.4MFY2025 · since FY2017: -$6.8M → -$170.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$170.4M | -201.4% |
| FY2024 | -$56.5M | +68.6% |
| FY2023 | -$179.8M | +21.6% |
| FY2022 | -$229.4M | +2.0% |
| FY2021 | -$234.0M | +3.8% |
| FY2020 | -$243.4M | -35.0% |
| FY2019 | -$180.3M | -22.7% |
| FY2018 | -$147.0M | -2070.6% |
| FY2017 | -$6.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating incomeGOSS Operating marginGOSS Operating cash flowGOSS Free cash flowGOSS Capital expendituresGOSS Return on equityGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Total liabilitiesGOSS Shareholders’ equityGOSS overview →